CARDIOVASCULAR CHARACTERIZATION OF DA-1 AND DA-2 DOPAMINE RECEPTOR AGONISTS IN ANESTHETIZED RATS

被引：46

作者：

CAVERO, I

THIRY, C

PRATZ, J

LAWSON, K

机构：

来源：

CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE | 1987年 / 9卷 / 5-6期

关键词：

D O I：

10.3109/10641968709161458

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：931 / 952

页数：22

共 13 条

[1]

CAVERO I, 1984, J PHARMACOL EXP THER, V228, P779

[2]

CAVERO I, 1987, UNPUB CARDIOVASCULAR

[3]

CAVERO I, 1987, IN PRESS FED P

[4]

HAHN RA, 1982, J PHARMACOL EXP THER, V223, P305

[5]

HAHN RA, 1984, J PHARMACOL EXP THER, V229, P132

[6] THE EFFECT OF ORAL FENOLDOPAM (SKF 82526-J), A PERIPHERAL DOPAMINE RECEPTOR AGONIST, ON BLOOD-PRESSURE AND RENAL-FUNCTION IN NORMAL MAN [J].

HARVEY, JN ;

WORTH, DP ;

BROWN, J ;

LEE, MR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (01) :21-27

[7]

LECHAIRE J, 1987, IN PRESS BR J PHARM

[8]

LEFEVREBORG F, 1987, IN PRESS CLIN PHARM

[9]

NAGAHAMA S, 1986, J PHARMACOL EXP THER, V239, P426

[10] THE DA1 RECEPTOR AGONIST FENOLDOPAM (SK-AND-F-82526) IS ALSO AN ALPHA-2-ADRENOCEPTOR ANTAGONIST [J].

OHLSTEIN, EH ;

ZABKOPOTAPOVICH, B ;

BERKOWITZ, BA .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 118 (03) :321-329

← 1 2 →